{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:12:05Z","timestamp":1790730725373,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.pathol.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T12:54:38Z","timestamp":1561035278000},"page":"518-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Autoantibodies in interstitial lung diseases"],"prefix":"10.1016","volume":"51","author":[{"given":"Brittany R.","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monalyssa C.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Bundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Klinken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona R.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"McLean-Tooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.pathol.2019.03.007_bib1","first-page":"v1","article-title":"Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society","volume":"63","author":"Bradley","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.pathol.2019.03.007_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib3","doi-asserted-by":"crossref","first-page":"123876","DOI":"10.1155\/2015\/123876","article-title":"Exploring clinical and epidemiological characteristics of interstitial lung diseases: rationale, aims, and design of a nationwide prospective registry\u2014the EXCITING-ILD Registry","volume":"2015","author":"Kreuter","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.pathol.2019.03.007_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/CE.S76549","article-title":"Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy","volume":"11","author":"Margaritopoulos","year":"2016","journal-title":"Core Evid"},{"key":"10.1016\/j.pathol.2019.03.007_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S2213-2600(16)30325-3","article-title":"The diagnosis of idiopathic pulmonary fibrosis: current and future approaches","volume":"5","author":"Martinez","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/resp.12588","article-title":"Idiopathic interstitial pneumonias with connective tissue diseases features: a review","volume":"21","author":"Cottin","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.pathol.2019.03.007_bib8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/resp.13163","article-title":"The interstitial lung disease multidisciplinary meeting: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia","volume":"22","author":"Prasad","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.pathol.2019.03.007_bib9","first-page":"E51","article-title":"Role of autoantibodies in the diagnosis of connective-tissue disease ILD (CTD-ILD) and interstitial pneumonia with autoimmune features (IPAF)","volume":"6","author":"Jee","year":"2017","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib10","first-page":"1264","article-title":"The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases","volume":"56","author":"Cotton","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.pathol.2019.03.007_bib11","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2017.10.002","article-title":"An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: the key role of anti-Ro52 antibodies","volume":"475","author":"Infantino","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pathol.2019.03.007_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.rmed.2013.01.006","article-title":"Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis","volume":"107","author":"Ando","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pathol.2019.03.007_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rmed.2016.10.017","article-title":"Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients","volume":"123","author":"Ahmad","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.chest.2017.03.004","article-title":"Idiopathic interstitial pneumonia associated with autoantibodies: a large case series followed over 1 year","volume":"152","author":"Collins","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pathol.2019.03.007_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.autrev.2015.09.003","article-title":"Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: our interdisciplinary rheumatology-pneumology experience, and review of the literature","volume":"15","author":"Ferri","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pathol.2019.03.007_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/cdli.3.4.374-377.1996","article-title":"Precise quantitation of antinuclear antibodies on HEp-2 cells without the need for serial dilution","volume":"3","author":"Hollingsworth","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.pathol.2019.03.007_bib19","series-title":"The Busselton Study: Mapping Population Health (Cardiovascular and Respiratory Disease Risk Factors in Busselton, Australia)","author":"Welborn","year":"1998"},{"key":"10.1016\/j.pathol.2019.03.007_bib20","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.rmed.2009.05.001","article-title":"Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia","volume":"103","author":"Fischer","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3349\/ymj.2015.56.3.676","article-title":"Significance of myositis autoantibody in patients with idiopathic interstitial lung disease","volume":"56","author":"Song","year":"2015","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.pathol.2019.03.007_bib22","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.rmed.2011.03.022","article-title":"Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias","volume":"105","author":"Watanabe","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib23","first-page":"389","article-title":"A\u00a064-year-old woman with interstitial lung disease and positive antibodies against aminoacyl-transfer RNA synthetases in the absence of myositis: presentation of an anti-PL-12 positive antisynthetase syndrome","volume":"73","author":"Ghysen","year":"2018","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.pathol.2019.03.007_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/qjmed\/hcy008","article-title":"Anti-aminoacyl tRNA synthetase antibody-positive clinically amyopathic dermatomyositis","volume":"111","author":"Ebisudani","year":"2018","journal-title":"QJM"},{"key":"10.1016\/j.pathol.2019.03.007_bib25","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00296-018-3991-7","article-title":"Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review","volume":"38","author":"Gonzalez-Moreno","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.pathol.2019.03.007_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000183754","article-title":"A\u00a0comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients","volume":"77","author":"Nozu","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.pathol.2019.03.007_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199659","article-title":"Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias","volume":"13","author":"Hozumi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2019.03.007_bib28","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/rheumatology\/ker236","article-title":"Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study","volume":"50","author":"Arulkumaran","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.pathol.2019.03.007_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1843.2004.00581.x","article-title":"Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides","volume":"9","author":"Homma","year":"2004","journal-title":"Respirology"},{"key":"10.1016\/j.pathol.2019.03.007_bib30","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar4550","article-title":"Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study","volume":"16","author":"Sada","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pathol.2019.03.007_bib31","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/resp.12763","article-title":"Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis","volume":"21","author":"Hosoda","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.pathol.2019.03.007_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.rmed.2012.10.018","article-title":"Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis","volume":"107","author":"Lee","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib33","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1378\/chest.10-2662","article-title":"Autoimmune-featured interstitial lung disease: a distinct entity","volume":"140","author":"Vij","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.pathol.2019.03.007_bib34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pathol.2016.03.014","article-title":"Low level autoantibodies can be frequently detected in the general Australian population","volume":"48","author":"Deshpande","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2019.03.007_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-017-0453-z","article-title":"Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features","volume":"17","author":"Ito","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.pathol.2019.03.007_bib36","first-page":"1600","article-title":"Anti-th\/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis","volume":"33","author":"Fischer","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pathol.2019.03.007_bib37","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/rheumatology\/kex266","article-title":"A\u00a0multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies","volume":"56","author":"Bossuyt","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.pathol.2019.03.007_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pathol.2016.03.012","article-title":"Diagnostic performance of a commercial immunoblot assay for myositis antibody testing","volume":"48","author":"Bundell","year":"2016","journal-title":"Pathology"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302518305488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302518305488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:24:40Z","timestamp":1758471880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302518305488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0031302518305488"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.03.007","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in interstitial lung diseases","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights reserved.","name":"copyright","label":"Copyright"}]}}